Simplification from Tenofovir plus Lamivudine or Emtricitabine plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir plus Lamivudine in Virologically-Suppressed-HIV-Infected Adults with Osteopenia: a pilot study
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2016
At a glance
- Drugs Atazanavir (Primary) ; Lamivudine; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 16 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 16 Aug 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.